Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520884 · ClinicalTrials.gov registry record · Phase 1
Ghrelin in Healthy and Frail Older Women
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00520884: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT00520884 is a Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00520884, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if giving women a hormone called "ghrelin" will increase levels of growth hormone in the blood and increase appetite. Ghrelin is a naturally occurring hormone that is produced mostly by the stomach and causes secretion of another hormone called growth hormone. It also increases short-term appetite and may lower the amount of inflammation in the body. Some people lose their appetite as they age and have unintentional weight loss. This may be caused by a break in the communication between the stomach and the brain. We are particularly interested in seeing if there is a difference in the effects of ghrelin in older women who have lost weight recently without wanting to and those who have not.
Interventions
- DRUG Ghrelin Infusion - Healthy
- DRUG Ghrelin Infusion - Frail
- OTHER Placebo Infusion -Healthy
- OTHER Placebo Infusion - Frail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00520884
The ClinicalTrials.gov registry entry for NCT00520884 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ghrelin Infusion - Healthy is the first listed.
NCT00520884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00520884 about?
NCT00520884 is a clinical study titled "Ghrelin in Healthy and Frail Older Women". The purpose of this research study is to see if giving women a hormone called "ghrelin" will increase levels of growth hormone in the blood and increase appetite. Ghrelin is a naturally occurring hormone that is produced mostly by the stomach and causes secretion of another hormone called growth hor...
What is the current status of trial NCT00520884?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2007-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00520884?
The interventions under investigation include: Ghrelin Infusion - Healthy (DRUG), Ghrelin Infusion - Frail (DRUG), Placebo Infusion -Healthy (OTHER), Placebo Infusion - Frail (OTHER).
Who is sponsoring clinical trial NCT00520884?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.